20:51:25:02.  Review of patient's record. A pharmacist shall review the patient's record at the time a prescription drug order or prescription refill request is presented for dispensing for the purpose of identifying any of the following conditions:

          (1)  Overutilization, use of a drug in quantities or for durations that put the patient at risk of an adverse medical result;

          (2)  Underutilization, use of a drug by a patient in an insufficient quantity to achieve a desired therapeutic goal;

          (3)  Therapeutic duplication, use of two or more drugs from the same therapeutic class in such a way that the combined daily dose puts the patient at risk of an adverse medical result;

          (4)  Drug-disease contraindications, the potential for or the occurrence of an undesirable alteration of the therapeutic effect of a given drug because of the presence of a disease condition in the patient or an adverse effect of the drug on the patient's disease condition;

          (5)  Adverse drug-drug interactions, the potential for or the occurrence of an adverse medical effect as a result of the patient using two or more drugs together;

          (6)  Incorrect drug dosage, the dosage lies outside the daily dosage range specified in predetermined standards listed in 42 C.F.R. § 456.703(f)(1), published in 57 Fed. Reg. 49,408 (November 2, 1992) as necessary to achieve therapeutic benefit. Dosage range is the strength multiplied by the quantity dispensed divided by days supply;

          (7)  Incorrect duration of drug treatment, the number of days of prescribed therapy exceeds or falls short of the recommendations contained in predetermined standards listed in 42 C.F.R. § 456.703(f)(1), published in 57 Fed. Reg. 49,408 (November 2, 1992);

          (8)  Drug-allergy interactions, the significant potential for or the occurrence of an allergic reaction as a result of drug therapy; or

          (9)  Clinical abuse or misuse.

          The pharmacist shall attempt to avoid or resolve any problems identified during the review and may, if necessary, consult with the practitioner.

          Source: 19 SDR 93, effective December 31, 1992.

          General Authority:SDCL 36-11-68.

          Law Implemented:SDCL 36-11-68.